The Health and Safety Executive (HSE), the agency for the United Kingdom (UK) REACH, has created a Rolling Action Plan (RAP) to increase understanding of the hazard and risk profile of two substances on the Great Britain (GB) market. HSE states that “we have sought to complement rather than replicate evaluation work that has been or will be performed by other regulatory regimes (such as via EU REACH).”
The two substances that have been added to the RAP are:
|Year||Substance||EC No||CAS RN||Initial grounds for concern|
|2022||Paraffin waxes and hydrocarbon waxes, chloro||264-150-0||63449-39-8||Environment: suspected PBT/vPvB
Exposure: wide dispersive use, high (aggregated) tonnage
|2022||2,2′-Diallyl-4,4′-sulfonyldiphenol||411-570-9||41481-66-7||Environment: potential endocrine disrupter
Human Health: suspected CMR
Exposure: wide dispersive use
|2023||To be agreed in next update (by May 31, 2023)||–||–||–|
|2024||To be agreed in update (by May 31, 2024)||–||–||–|
HSE may have limited information on these substances and will consider data from a number of sources:
- The GB specific data within the UK database (Comply with UK REACH-IT);
- UK REACH processes (such as dossier evaluation), which will also develop with the embedding of the UK REACH system past the first year of operation; and
- Other intelligence — such as horizon scanning of other regimes, both domestic (g., GB Classification, Labelling and Packaging regulation) and international (e.g., European Union (EU) REACH and other regulatory systems from other countries).
Companies that import, manufacture, use, or place these substances on the market should keep abreast of developments.